Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MYCN and HDAC5 transcriptionally repress <i>CD9</i> to trigger invasion and metastasis in neuroblastoma

27 Aug 2016

Abstract excerpt

// Johannes Fabian 1,2 , Desirée Opitz 1 , Kristina Althoff 3 , Marco Lodrini 1,4 , Barbara Hero 5 , Ruth Volland 5 , Anneleen Beckers 6,7 , Katleen de Preter 6,7 , Anneleen Decock 6,7 , Nitin Patil 8 , Mohammed Abba 8 , Annette Kopp-Schneider 9 , Kathy Astrahantseff 4 , Jasmin Wünschel 1,4 , Sebastian Pfeil 4 , Maria Ercu 4 , Annette Künkele 4 , Jamie Hu 1,10 , Theresa Thole 1,4 , Leonille...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Cancer therapeutics and mechanisms
Share to Neuroblastoma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27572323
DOI: 10.18632/oncotarget.11662

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MYCN and HDAC5 transcriptionally repress <i>CD9</i> to trigger invasion and metastasis in neuroblastomaPMID 27572323Read ↗

Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic Drugs.Semantic proximity Read ↗

<i>GRHL1</i>Acts as Tumor Suppressor in Neuroblastoma and Is Negatively Regulated by MYCN and HDAC3Semantic proximity Read ↗

MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children’s oncology groupSemantic proximity Read ↗

MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4Semantic proximity Read ↗

A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in NeuroblastomaSemantic proximity Read ↗

Targeting class I histone deacetylases in cancer therapySemantic proximity Read ↗

Epigenetic Dysregulation in MYCN-Amplified NeuroblastomaSemantic proximity Read ↗

Nedd4-Binding Protein 1 and TNFAIP3-Interacting Protein 1 Control MHC-1 Display in NeuroblastomaSemantic proximity Read ↗

Anti-GD2 antibody therapy alters the neuroblastoma tumor microenvironment and extends survival in <i>TH-MYCN</i> miceSemantic proximity Read ↗

Targeting of epigenetic regulators in neuroblastomaSemantic proximity Read ↗

Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastomaSemantic proximity Read ↗

An overview of neuroblastoma cell lineage phenotypes and in vitro models.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.